NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,125,000 | +15.4% | 106,238 | -1.9% | 0.68% | +5.9% |
| Q4 2020 | $1,842,000 | -6.8% | 108,342 | -9.1% | 0.64% | -30.4% |
| Q3 2020 | $1,977,000 | -29.7% | 119,198 | -1.8% | 0.92% | -34.5% |
| Q2 2020 | $2,813,000 | +26.8% | 121,439 | -2.3% | 1.41% | +3.7% |
| Q1 2020 | $2,219,000 | -12.8% | 124,292 | +5.4% | 1.36% | +21.7% |
| Q4 2019 | $2,545,000 | +28.7% | 117,910 | +8.6% | 1.11% | +12.3% |
| Q3 2019 | $1,977,000 | -42.3% | 108,540 | +12.8% | 0.99% | -42.2% |
| Q2 2019 | $3,424,000 | – | 96,226 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |